People · Operator
Named in public records as an officer, director or promoter · active 2011–2021 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Wellness Indicators, Inc. | — | Biotechnology | Seed | $2.6M | $26.6M | 2011 |
| Lumoptik, Inc. | — | Other Health Care | Pre-Seed | $1.0M | $19.9M | 2019 |
Frank Lyman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frank Lyman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeff Enslin | 1 | 2 |
| Andrew Dahl | 1 | 2 |
| Harry Silverman | 1 | 1 |
| Denis Callewaert | 1 | 1 |
| Cole Hatfield | 1 | 1 |
| Kurtz Sanford | 1 | 1 |
| Thomas Janicki | 1 | 1 |
| Don Verlee | 1 | 1 |
| Schumann Robert | 1 | 1 |
| Brian Kearns | 1 | 1 |
| Andy Alexander | 1 | 1 |
| Arthur Janicki | 1 | 1 |
| Michael Sutcliffe | 1 | 1 |
| Denis M Callewaert | 1 | 1 |
| Timothy Sell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.